bioRxiv/medRxiv TRiP Review Activity

426 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 28: Articles 271-280  | Next

Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinoma
Kato, T., Jenkins, R. P., Derzsi, S., Tozluoglu, M., Rullan, A., Hooper, S., Chaleil, R. A. G., Fu, X., Joyce, H., Thavaraj, S., Bates, P. A., Sahai, E.
10.1101/2021.11.24.469674 — Posted: 2021-11-24 — Discussion: 2022-12-08  eLife
THEM6-mediated lipid remodelling sustains stress resistance in cancer
Blomme, A., Peter, C., Mui, E., Rodriguez Blanco, G., Mason, L. M., Jamieson, L. E., McGregor, G. H., Lilla, S., Ntala, C., Patel, R., Thiry, M., Kung, S. H., Ford, C. A., Rushworth, L. K., McGarry, D. J., Mason, S., Repiscak, P., Nixon, C., Salji, M. J., Markert, E., MacKay, G. M., Kamphorst, J. J., Graham, D., Faulds, K., Fazli, L., Gleave, M. E., Avezov, E., Edwards, J., Yin, H., Sumpton, D., Blyth, K., Close, P., Murphy, D. J., Zanivan, S. R., Leung, H. Y.
10.1101/2021.04.04.438378 — Posted: 2021-04-04 — Discussion: 2022-11-21  EMBO Press
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models
Sauer, C. M., Heider, K., Belic, J., Boyle, S. E., Hall, J. A., Couturier, D.-L., An, A., Vijayaraghavan, A., Reinius, M. A., Hosking, K., Vias, M., Rosenfeld, N., Brenton, J. D.
10.1101/2022.01.15.476442 — Posted: 2022-01-18 — Discussion: 2022-11-21  EMBO Press
Heterogeneity of the Cancer Cell Line Metabolic Landscape
Shorthouse, D., Bradley, J., Critchlow, S., Bendtsen, C., Hall, B. A.
10.1101/2021.08.19.456093 — Posted: 2021-08-19 — Discussion: 2022-11-21  EMBO Press
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
Meister, M. T., Groot Koerkamp, M. J. A., de Souza, T., Breunis, W. B., Frazer-Mendelewska, E., Brok, M., DeMartino, J., Manders, F., Calandrini, C., Kerstens, H. H. D., Janse, A., Dolman, M. E. M., Eising, S., Langenberg, K. P. S., van Tuil, M., Knops, R. R. G., Terwisscha van Scheltinga, S., Hiemcke-Jiwa, L. S., Flucke, U., Merks, J. H. M., van Noesel, M. M., Tops, B. B. J., Hehir-Kwa, J. Y., Kemmeren, P., Molenaar, J. J., van de Wetering, M., van Boxtel, R., Drost, J., Holstege, F. C. P.
10.1101/2022.01.03.474504 — Posted: 2022-01-04 — Discussion: 2022-11-21  EMBO Press
Low HER2 enables dedifferentiation and transformation of normal breast epithelial cells via chromatin opening
Hayat, A., Carter, E., King, H. W., Ors, A., Doe, A., Teijeiro, S. A., Charrot, S., Godinho, S., Cutillas, P. R., Mohammed, H., Grose, R. P., Ficz, G.
10.1101/2022.09.06.506760 — Posted: 2022-09-06 — Discussion: 2022-11-17  Review Commons
Defining cellular population dynamics at single cell resolution during prostate cancer progression
Germanos, A. A., Arora, S., Zheng, Y., Goddard, E. T., Coleman, I. M., Ku, A. T., Wilkinson, S., Amezquita, R. A., Zager, M., Long, A., Yang, Y. C., Bielas, J. H., Gottardo, R., Ghajar, C. M., Nelson, P. S., Sowalsky, A. G., Setty, M., Hsieh, A. C.
10.1101/2022.03.02.482711 — Posted: 2022-03-04 — Discussion: 2022-11-16  eLife
EZH2/ hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression
Lin, Z.-S., Chung, C.-C., Liu, Y.-C., Chang, C.-H., Liu, H.-C., Liang, Y.-Y., Huang, T.-L., Chen, T.-M., Lee, C.-H., Tang, C.-H., Chen, Y.-H., Hung, M.-C.
10.1101/2022.06.07.495151 — Posted: 2022-06-09 — Discussion: 2022-11-07  eLife
WILD-seq: Clonal deconvolution of transcriptomic signatures of sensitivity and resistance to cancer therapeutics in vivo.
Wild, S. A., Cannell, I. G., Kania, K., CRUK IMAXT Grand Challenge Team, , Hannon, G. J., Sawicka, K.
10.1101/2021.12.09.471927 — Posted: 2021-12-10 — Discussion: 2022-11-07  eLife
Co-deletion of ATAD1 with PTEN primes cells for BIM-mediated apoptosis
Winter, J. M., Fresenius, H. L., Keys, H. R., Cunningham, C. N., Ryan, J., Sirohi, D., Berg, J. A., Tripp, S. R., Barta, P., Agarwal, N., Letai, A., Sabatini, D. M., Wohlever, M. L., Rutter, J.
10.1101/2021.07.01.450781 — Posted: 2021-07-03 — Discussion: 2022-11-03  eLife

Evaluation Sources